This site is intended for Healthcare professionals only.
Loading Events

« All Events

  • This event has passed.

ICON 2016 – 34th of Indian Cooperative Oncology Network and Molecular Oncology Society

March 11, 2016 - March 13, 2016

34th ICON Conference of 34th of Indian Cooperative Oncology Network and Molecular Oncology Society along with International Clinical Trials Workshop (In conjunction with ASCO and NCI, USA) to be held from 11th to 13th March 2016 at HICC, Hyderabad.

With newer and more effective therapies for the treatment of cancer, the need for universally accepted, standardized criteria for staging and response assessment becomes even more critical.   Such guidelines permit the reporting of uniform endpoints, facilitate comparisons amongst studies, help identify promising regimens, and facilitate evaluation and approval by regulatory agencies.

Conference aims to discuss the recent advancements in molecular oncology & personalized medicine and its implementation in day to day practice.


Highlights of the conference :

  • Launch of new WHO Classification Blue Book – Staging and Risk Assessment of Lymphomas
  • Young ICON Activity
  • Competition for abstracts and research proposals
  • Symposia on Recent Advances
  • Dedicated Session on Networking


Theme: Molecular Oncology & Personalized Medicine in Day to Day Practice
Time Topic/Speaker
12.00 PM-01.30 PM Registration & Lunch
01.30 PM-02.15 PM Special Session (N) TALK beyond ALK first line therapy
02.15 PM-03.30 PM Molecular Oncology
02.15 PM-02.30 PM Are all EGFR mutations the same?
02.30 PM-02.45 PM Cell free DNA and RNA :New Moleculer Markers in Cancer Management
02.45 PM-03.00nPM Immunotherapy: Are there any predictive Biomarkers?
03.00 PM-03.30 PM Panel Discussion – Intratumour macro and micro heterogeneity: the ultimate challenge for precision cancer medicine?
03.30 PM-05.00 PM SARCOMA
03.30 PM-03.55 PM Debate 1:Histology driven therapy in STS : is it ready for prime time ?
03.55 PM-04.20 PM Debate 2:HD- Mtx based chemotherapy is mandatory in osteosarcoma.
04.20 PM -04.45 PM Debate 3: In Advanced Sarcoma: Understanding molecular pathways for treatment optimization is mandatory
04.45 PM-05.10 PM Sequencing sarcoma therapies in order to maximize outcomes
05.10PM -05.50 PM Leukemia
05.10PM 05.30 PM New Molecular targets in the treatment of Childhood Acute Lymphoblastic Leukemia
05.30PM-05.50 PM Resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia : strategies for management
05.50-06.00 PM Neurooncology
05.50 PM-06.05 PM Emerging WHO classification:
06.05 PM-06.15 PM Is VEGF inhibition relevant in treatment of Recurrent Glioma?
06.15 PM-06.40 PM Panel Discussion – Chemotherapy in low grade glioma:Newer Advances
06.40 PM-07.10 PM Session: Pfizer mRCC: Focus on 2nd Line therapies
07.10 PM-07.40 PM PREDINNER (Intas) Doceaqualip : Indian data on Metastatic Breast Cancer
07.30 PM-08.30 PM DINNER Symposium



“34th ICON Conference and 2nd Molecular Oncology Society Conference” (Hall B) Friday 11th March 2016
Theme: Molecular Oncology & Personalized Medicine in Day to Day Practice
Time Topic/Speaker
11th March 2015 International Clinical Trial Workshop – ASCO 2016
09.00 am to 09.30 am Registration and Preconference Assessment
09.30 am to 09.45am Welcome, Introduction and Workshop Objectives
09.45 am to 10.15 am Value of Background data in formulating research plan
10.15 am to 11.00 am Good Clinical Practice
11.00 am to 11.30 am Break
11.30 am to 12.15 pm Ethical Considerations :
12.15 pm to 01.00 pm Phase II Trial design Challenges in the era of Targeted and immunotherapies.
01.00 pm to 01.45 pm Lunch
01.45 pm to 03.15 pm: Design and Methodology of Clinical Trials : Dr David Kerr
                  Phase I design
                  Phase II designs
Single arm design
One and two-stage designs
Randomized designs
Adaptive designs
                  Variability and Bias
                  Descriptive statistics
                  Common plots: Kaplan Meier, Waterfall, Forest plot
03.15 pm to 03.45 pm Break
03.45 pm to 06.00 pm Breakout Sessions (10 groups)
06.00 pm to 06.30 pm Homework Assignments
06.30 pm to 06.45 pm Official Inauguration Function


Theme: Molecular Oncology & Personalized Medicine in Day to Day Practice
Time Topic/Speaker
08.00 AM-06.00 PM Registrations
08.30 AM-09.30 AM Breakfast Symposium
09.30 AM-1100 AM Breast Cancer
09.30 AM-09.45 AM The new genome driver classification of Breast Cancer
09.45 AM-10.00AM Heterogeneity in Her2 positive breast cancer and usefulness of dual Her 2 Blockade
10.00AM-10.20 AM Debate :Is Bevacizumab still relevant in the management of MBC?
10.20AM-10.45 AM Panel Discussion : Endocrine resistance? Have we finalized the algorithm?
10:45 AM-11:10 AM Panel Discussion:Case Based discussion Personalized Medicine in breast cancer: Focus on Moleculer Biology
11:00am -12:30 PM Head and Neck cancer
11-11:25 AM HPV positive HNSCC:To deescalate therapy or not?
11:30 AM -12:00 PM Targeting Advanced HNSCC: Is it worth it?
12:00PM-12:30 PM Therapeutic Decision Making in Borderline and locally advanced HNSCC
12:00 PM-01:00 PM Lung Cancer
12:00 PM-12:15 PM Immunotherapy in lung cancer: Broadening Horizons
12:30 PM-01:15 PM Pre Lunch Symposium BI
12:50 PM -01:15 PM Panel Discussion : Moleculer target in NSCLC.EGFR TKIs :Treatment Choices far too many..
01:15 PM-02:00 PM (Lunch Symposium)
01:30 PM-02:00 PM Panel Discussion : Challenges in delivery of chemoradiation in Lung Cancer
02.00 PM-02.30 PM Panel Discussion : Incorporating Liquid Biopsies and NGS in management of Lung Cancer
02.30 PM-04.00 PM GI Cancers
02.30 PM-03.30 PM Debate : Left and Right sided colon cancers are same
03.30 PM-04.00 PM Panel Discussion : Targeting molecular pathways in neuroendocrine tumors
04.00 PM-05.00 PM Young ICON
Chairpersons Dr. Harit Chaturvedi Delhi,Dr Ravikumar Saxena Hyderabad
05.00 PM-05.50 PM Gynae Oncology
5.00 PM-05.30 PM Debate : Ovarian Cancers: Target or not to Target
05.30 PM-06.00 PM Panel Discussion : Adjuvant therapy in Endometrial cancer
06.00 PM-06.30 PM Genitourinary Cancers
06.00 PM-06.30 PM Debate: Radiotherapy Vs Robotic Surgery in early Prostatic carcinoma
07.00 PM-07.30 PM Inauguration
07.30 PM-08.30 PM Dinner Symposium
Selection and sequencing of Targets mRCC: Forming a consensus


“34th ICON Conference and 2nd Molecular Oncology Society Conference” (Hall B) Saturday 12th March 2016
Theme: Molecular Oncology & Personalized Medicine in Day to Day Practice
12th March 2016 International Clinical Trial Workshop – ASCO 2016
Time Topic/Speaker
09.00 am to 09.15 am Homework revisited
09.15 am to 09.45 am Regulatory Considerations in clinical trials – USFDA, DCGI :
09.45 am to 10.30 am Informed Consent Forms :
10.30 am to 10.45 am Break
10.45 am to 11.15 am Writing a Concept outline:
11.15 am-11.45 am How clinical trials are funded? Dr.
11.45am -12.30 pm Data and Safety Monitoring of Clinical Studies.
12.30 pm to 01.00 pm Report writing, presentation and publications – Dr Gilberto Lopes
01.00 pm to 01.30 pm Lunch
01.30 pm to 02.45 pm Clinical Cancer Research Concepts : Statistical considerations
  Introduction Phase I trials
  Single Arm Phase II
  Randomized trials Phase II and Phase III
  Phase IV
Statistics (Randomized Trials)
  Non-inferiority and Superiority Trials
  Hypothesis Testing
Sample size, Power, Clinical Significance vs Statistical significance
  Estimating sample size parameters
  Endpoints
  Surrogate & Composite Endpoints
02.45 pm to 03.00 pm Break
03.00 pm to 05.00 pm Breakout Sessions – 10 Groups with 2 faculty facilitators per group *
05.00 pm to 05.30 pm Feedback and post workshop assessment –
05.30 pm to 06.00 pm Certificate distribution to successful participants


08.00 AM-09.00 AM Breakfast Session
09.00 AM-09.30 AM (N) Molecular monitoring in CML and the prospects for treatment-free remissions: Path to Cure..
08.30 AM-08.45 AM Dr. Elaine Jaffe: Introduction to the updated WHO classification of Lymphoma
08.35 AM-09.30 AM Dr. Elias Campo: Whats the change in Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular lymphoma, Marginal Zone B-Cell Lymphomas, Lymphoplasmacytic lymphoma
09.45 AM-10.00 AM Discussion :
10.00 AM-10.20 AM Tea/Coffee Break
10.20 AM-11.05 AM Dr. Wing Chan: Whats the change in Diffuse Large B-cell Lymphomas
11.20 AM-11.35 AM DISCUSSION
11.35 AM-12.20 PM Dr. Elaine Jaffe: Whats new in Grey Zone lymphomas- Burkitt and Diffuse Large B-Cell lymphoma Lymphoma; Primary Mediastinal Large B-cell Lymphoma and Classical Hodgkin lymphoma; Nodular Lymphocyte Predominant Hodgkin Lymphoma and T-Cell Rich Large B-Cell Lymphoma
12.35 PM-12.50 PM Discussion
12.50 PM-01.20 PM Lunch Symposium
01.20 PM-01.50 PM Dr. Wing Chan: Whats new in Peripheral T-cell Lymphomas (Nodal and Extranodal)
02.05 PM-02.20 PM Discussion


34th ICON Conference and 2nd Molecular Oncology Society Conference (Hall B) Sunday 13th March 2016
Theme: Molecular Oncology & Personalized Medicine in Day to Day Practice
Sunday 13th March 2016 -Medicolegal Workshop (Parallel Session)
Program Director: Dr Purvish parikh
Co-Director :
09.00 to 9.30 AM Cases in Courts and Consumer Courts against doctors have increased by 400%
09.30 to 10.00 AM What to avoid in telephonic/ whatsapp communication/ consultation
10.00 to 10.30 AM How documentation can save you from crores
10.30 to 11.00 AM Tea/ Coffee Break
11.00 to 11.20 AM Dealing with a aggressive patient/ family
11.20 to 11.40AM What to do when faced with complaint letter / legal notice / summons
11.40 to 12.00 AM Pitfalls in Medical Indemnity
12.00 to 01.00 PM Questions and Answers

Date: 11-13 March 2016

Venue: Hyderabad International Convention Center, Near P.O Bag 1101 Kondapur, HITECH City,
Hyderabad, Telangana 500081

For Registration

for more details log on


Molecular Oncology Society SCIENTIFIC PROGRAM


Hyderabad International Convention Center, Near P.O Bag 1101 Kondapur, HITECH City, Hyderabad, Telangana 500081
A-1107, Siddhi Vinayak Towers, Behind DCP office, off SG Highway, Makarba,
Ahmedabad, 380051 India
+ Google Map